Wound healing is a dynamic, interactive, and complex process that involves a series of events, including inflammation, migration, proliferation, granulation tissue formation, and matrix remodeling. Despite the high frequency of serious slow-healing wounds, there is still no adequate therapy. The aim of this study is to evaluate a new highly diluted acetylcholine (Ach) formulation obtained through a sequential kinetic activation (SKA) method applied to a wound healing in vivo model to verify the hypothesis that a low dose of Ach could be a more physiological stimulus for healing, by stimulating muscarinic and nicotinic receptors and their related intracellular pathways.
Approach:
Two different concentrations (10 fg/mL and 1 pg/mL) and two formulations (either kinetically or nonkinetically activated) of Ach were used to verify the wound healing process. Area closure, histological aspect, and nicotinic and muscarinic receptors, matrix metalloproteinase 9 (MMP-9), Nestin, and von Willebrand's factor have been assessed by Western blot or ELISA and compared to 147 ng/mL Ach, used as positive control. Moreover, the systemic effect through plasmatic radical oxygen species (ROS) production and Ach concentration has been evaluated.
Results:
Ach SKA 1 pg/mL revealed a significant capacity to restore the integrity of tissue compared to other formulation and this effect was more evident after a single administration.
Innovation:
Topical application on skin of Ach SKA 1 pg/mL accelerates wound closure stimulating non-neuronal cholinergic system.
Conclusion:
Our results demonstrate for the first time the importance in an in vivo model of highly diluted SKA Ach during wound healing, suggesting a potential use in skin disease.
Get full access to this article
View all access options for this article.
References
1.
KurzenH, WesslerI, KirkpatrickCJ, KawashimaK, GrandoSA. The non-neuronal cholinergic system of human skin. Horm Metab Res, 2007; 39:125–135.
2.
SlominskiAT, ZmijewskiMA, SkobowiatC, ZbytekB, SlominskiRM, SteketeeJD. Sensing the environment: regulation of local and global homeostasis by the skin's neuroendocrine system. Adv Anat Embryol Cell Biol, 2012; 212:v, vii, 1–115.
JainN, KalailingamP, TanKW, TanHB, SngMK, ChanJS, et al.Conditional knockout of N-WASP in mouse fibroblast caused keratinocyte hyper proliferation and enhanced wound closure. Sci Rep, 2016; 6:38109.
5.
GoldmanR. Growth factors and chronic wound healing: past, present, and future. Adv Skin Wound Care, 2004; 17:24–35.
6.
BranskiLK, PereiraCT, HerndonDN, JeschkeMG. Gene therapy in wound healing: present status and future directions. Gene Ther, 2007; 14:1–10.
7.
ZahorecP, KollerJ, DanisovicL, BohacM. Mesenchymal stem cells for chronic wounds therapy. Cell Tissue Bank, 2015; 16:19–26.
8.
BuchbergerB, FollmannM, FreyerD, HuppertzH, EhmA, WasemJ. The evidence for the use of growth factors and active skin substitutes for the treatment of non-infected diabetic foot ulcers (DFU): a health technology assessment (HTA). Exp Clin Endocrinol Diabetes, 2011; 119:472–479.
9.
SpäterT, FruehFS, MetzgerW, MengerMD, LaschkeMW. In vivo biocompatibility, vascularization, and incorporation of Integra® dermal regenerative template and flowable wound matrix. J Biomed Mater Res B Appl Biomater, 2016; 106:52–60.
10.
FaniaL, ZampettiA, GuerrieroG, FelicianiC. Alteration of cholinergic system in keratinocytes cells produces acantholysis: a possible use of cholinergic drugs in pemphigus vulgaris. Antiinflamm Antiallergy Agents Med Chem, 2012; 11:238–242.
11.
UbertiF, BardelliC, MorsanutoV, GhirlandaS, CochisA, MolinariC. Stimulation of the nonneuronal cholinergic system by highly diluted acetylcholine in keratinocytes. Cells Tissues Organs, 2016; 203:215–230.
12.
BeckB, ZholosA, SydorenkoV, RoudbarakiM, Lehen'kyiV, BordatP, et al.TRPC7 is a receptor-operated DAG-activated channel in human keratinocytes. J Invest Dermatol, 2006; 126:1982–1993.
13.
GrandoSA, KistDA, QiM, DahlMV. Human keratinocytes synthesize, secrete, and degrade acetylcholine. J Invest Dermatol, 1993; 101:32–36.
14.
GrandoSA, PittelkowMR, SchallreuterKU. Adrenergic and cholinergic control in the biology of epidermis: physiological and clinical significance. J Invest Dermatol, 2006; 126:1948–1965.
15.
GrandoSA. Cholinergic control of epidermal cohesion. Exp Dermatol, 2006; 15:265–282.
16.
GrandoSA. Pemphigus autoimmunity: hypotheses and realities. Autoimmunity, 2011; 45:7–35.
17.
GariboldiS, PalazzoM, ZanobbioL, DusioGF, MauroV, SolimeneU, et al.Low dose oral administration of cytokines for treatment of allergic asthma. Pulm Pharmacol Ther, 2009; 22:497–510.
18.
D'AmicoL, RuffiniE, FerraciniR, RoatoI. Low dose of IL-12 stimulates T cell response in cultures of PBMCs derived from non-small cell lung cancer patients. J Cancer Ther, 2012; 3:337–342.
19.
BaryginaV, BecattiM, LottiT, MorettiS, TaddeiN, FiorilloC. Treatment with low-dose cytokines reduces oxidative-mediated injury in perilesional keratinocytes from vitiligo skin. J Dermatol Sci, 2015; 79:163–170.
20.
RadiceE, MirandaV, BelloneG. Low-doses of sequential-kinetic-activated interferon-γ enhance the ex vivo cytotoxicity of peripheral blood natural killer cells from patients with early-stage colorectal cancer: a preliminary study. Int Immunopharmacol, 2014; 19:66–73.
21.
RobertiML, RicottiniL, CapponiA, SclauzeroE, VicentiP, FiorentiniE, et al.Immunomodulating treatment with low dose interleukin-4, interleukin-10 and interleukin-11 in psoriasis vulgaris. J Biol Regul Homeost Agents, 2014; 28:133–139.
22.
BrodSA, KhanM. Oral administration of IFN-alpha is superior to subcutaneous administration of IFN-alpha in the suppression of chronic relapsing experimental autoimmune encephalomyelitis. J Autoimmun, 1996; 9:11–20.
23.
AvvakumovEG, ChizhevskayaSV, StoyanovES, PovetkinaMV, ChekmarevAM, ShafirovVL, et al.Influence of the nature of components in mechanically activated mixture of zirconium and silicon oxides on solid-phase synthesis of zircon. Russ J Appl Chem, 1999; 72:1498–1503.
24.
DunnL, ProsserHC, TanJT, VanagsLZ, NgMK, BursillCA. Murine model of wound healing. J Vis Exp, 2013; 28:e50265.
25.
DasS, SinghG, MajidM, ShermanMB, MukhopadhyayS, WrightCS, et al.Syndesome therapeutics for enhancing diabetic wound healing. Adv Healthc Mater, 2016; 5:2248–2260.
26.
JainAK, Tewari-SinghN, InturiS, OrlickyDJ, WhiteCW, AgarwalR. Histopathological and immunohistochemical evaluation of nitrogen mustard-induced cutaneous effects in SKH-1 hairless and C57BL/6 mice. Exp Toxicol Pathol, 2014; 66:129–138.
Buszewska-ForajtaM, SilukD, Daghir-WojtkowiakE, SejdaA, StaśkowiakD, BiernatW, et al.Studies of the effect of grasshopper abdominal secretion on wound healing with the use of murine model. J Ethnopharmacol, 2015; 176:413–423.
PintoNC, Cassini-VieiraP, Souza-FagundesEM, BarcelosLS, CastañonMC, ScioE. Pereskia aculeata Miller leaves accelerate excisional wound healing in mice. J Ethnopharmacol, 2016; 194:131–136.
32.
KampaM, NistikakiA, TsaousisV, MaliarakiN, NotasG, CastanasE. A new automated method for the determination of the total antioxidant capacity (TAC) of human plasma, based on the crocin bleaching assay. BMC Clin Pathol, 2002; 2:3–18.
33.
LattuadaD, UbertiF, ColciaghiB, MorsanutoV, MaldiE, SquarzantiDF, et al.Fimbrial cells exposure to catalytic iron mimics carcinogenic changes. Int J Gynecol Cancer, 2015; 25:389–398.
34.
EmingSA, MartinP, Tomic-CanicM. Wound repair and regeneration: mechanisms, signaling, and translation. Sci Transl Med, 2014; 6:265sr6.
35.
RajendranES. Homeopathy as a supportive therapy in cancer. Homeopathy, 2004; 93:99–102.
36.
SunilaES, KuttanR, PreethiKC, KuttanG. Dynamized preparations in cell culture. Evid Based Complement Alternat Med, 2009; 6:257–263.
37.
WittCM, LüdtkeR, WillichSN. Homeopathic treatment of patients with psoriasis—a prospective observational study with 2 years follow-up. J Eur Acad Dermatol Venereol, 2009; 23:538–543.
38.
KhoMM, BouvyAP, CadoganM, KraaijeveldR, BaanCC, WeimarW. The effect of low and ultra-low dosages Thymoglobulin on peripheral T, B and NK cells in kidney transplant recipients. Transpl Immunol, 2012; 26:186–190.
KlapprothH, ReinheimerT, MetzenJ, MünchM, BittingerF, KirkpatrickCJ, et al.Non-neuronal acetylcholine, a signalling molecule synthezised by surface cells of rat and man. Naunyn Schmiedebergs Arch Pharmacol, 1997; 355:515–523.
